Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.
Respiratory syncytial virus (RSV) is one of the most important causes of upper and lower respiratory tract infections in infants and young children, for which no effective treatment is currently available. Although the mechanisms of RSV-induced airway disease remain incompletely defined, the lung inflammatory response is thought to play a central pathogenetic role. In the past few years, we and others have provided increasing evidence of a role of reactive oxygen species (ROS) as important regulators of RSV-induced cellular signaling leading to the expression of key proinflammatory mediators, such as cytokines and chemokines. In addition, RSV-induced oxidative stress, which results from an imbalance between ROS production and airway antioxidant defenses, due to a widespread inhibition of antioxidant enzyme expression, is likely to play a fundamental role in the pathogenesis of RSV-associated lung inflammatory disease, as demonstrated by a significant increase in markers of oxidative injury, which correlate with the severity of clinical illness, in children with RSV infection. Modulation of ROS production and oxidative stress therefore represents a potential novel pharmacological approach to ameliorate RSV-induced lung inflammation and its long-term consequences.
Department of Pediatrics, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.
Roberto P
RP
Garofalo
Deepthi
D
Kolli
Antonella
A
Casola
D006801:Humans; D010084:Oxidation-Reduction; D026361:Reactive Nitrogen Species / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D018357:Respiratory Syncytial Virus Infections / Q000378:metabolism* / Q000628:therapy*; D015398:Signal Transduction
D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species